U.S. Healthtech Stock News

Ouster, Inc. has reported first-quarter 2026 results with revenue of US$48.58 million and a net loss of US$17.47 million, while also unveiling its Rev8 OS family of digital lidar sensors featuring native color, longer range, and higher resolution capabilities. The launch of Rev8, with its native color sensing and functional safety focus, marks a significant step in Ouster’s push to differentiate its lidar technology for automotive, industrial, and smart infrastructure customers. We’ll now...

Chipotle Mexican Grill (CMG) is back in focus after Q1 2026 earnings showed revenue of US$3.09b with net income of US$302.82m, alongside the first positive comparable sales and transaction growth in over a year. See our latest analysis for Chipotle Mexican Grill. The latest Q1 update, new store opening plans and leadership changes in marketing and digital come against a weaker share price backdrop, with a 90 day share price return decline of 19.08% and a 1 year total shareholder return...

In recent weeks, Symbotic entered a new warehouse automation agreement with Associated Wholesale Grocers for its Gulf Coast facility and reported record throughput of over 6.5 million cases processed in a single day, alongside unveiling its next-generation high-density storage structure. Together, these developments highlight how Symbotic’s AI-enabled platform is being put to work in real grocery distribution while advancing its core warehouse technology. We’ll now explore how this new AWG...

Soluna Holdings recently filed a US$2.66 million shelf registration for up to 2,459,400 common shares and announced a new Bitcoin Mining as a Service partnership with Sazmining at its wind-powered Project Dorothy in West Texas. The company also regained compliance with Nasdaq’s minimum bid price requirement in late April 2026, removing the immediate risk of delisting and reinforcing its renewable-powered computing narrative. Next, we’ll examine how regaining Nasdaq compliance shapes Soluna’s...

In the first quarter of 2026, Orchid Island Capital, Inc. reported a US$19.96 million net loss, or US$0.11 basic loss per share from continuing operations, compared with a net profit in the prior-year period, and confirmed it had completed its long-running share repurchase program with 6,257,826 shares bought back for US$84.80 million since 2015. This shift from profit to loss, following years of buybacks that retired more than a quarter of the company’s shares, raises questions about how...

Rockwell Automation Q2 2026 earnings snapshot Rockwell Automation (ROK) opened its Q2 2026 earnings season with Q1 fiscal 2026 revenue of US$2.1 billion and basic EPS of US$2.71. This provides a reference point for how investors may assess the current US$435.93 share price against recent performance. The company reported quarterly revenue of US$2.0 billion in Q2 2025, US$2.3 billion in Q4 2025, and US$2.1 billion in Q1 2026. Over the same periods, basic EPS was US$2.22 in Q2 2025, US$1.23 in...

Why CareDx stock is getting attention now CareDx (CDNA) has caught investor interest after recent share price moves, with the stock showing a mix of shorter term pressure and stronger longer term returns that raise fresh questions about valuation and risk. See our latest analysis for CareDx. The recent pullback, including a 1-day share price return of -1.24% and 7-day share price return of -5.52%, comes after a stronger 1-year total shareholder return of 45.98%. This suggests momentum has...

Why Cognex’s latest AI vision launch matters for the stock Cognex (CGNX) is back in focus after quarterly results beat expectations and the company rolled out its modular In-Sight 6900 Vision Controller, a new AI-powered system aimed at complex industrial inspection workloads. See our latest analysis for Cognex. The recent In-Sight 6900 launch and stronger quarterly results have arrived alongside powerful share price momentum, with a 90-day share price return of 44.44% and a 1-year total...

Ball (BALL) has just reported Q1 2026 results with investors looking back at recent momentum, including Q4 2025 revenue of US$3.3b, basic EPS of US$0.74 and trailing twelve month EPS of US$3.33 and net income of US$912m, set against a share price of US$57.11. Over the last few quarters revenue has moved from US$2.9b in Q4 2024 to around US$3.3b in Q4 2025, while quarterly EPS has ranged from a small loss in Q4 2024 to US$1.19 in Q3 2025 and US$0.74 in Q4 2025, giving investors a clearer view...

If you are wondering whether Biogen's current share price lines up with its underlying value, the recent performance gives you plenty to think about. The stock closed at US$189.13 recently, with returns of 3.1% over 7 days, 6.6% over 30 days, 6.4% year to date and 61.9% over the past year. The 3 year and 5 year returns sit at 39.8% and 32.1% declines respectively. These moves come as Biogen stays in focus in the large cap biotech space, with ongoing attention on its pipeline and portfolio...

Event context and recent stock performance Apellis Pharmaceuticals (APLS) has drawn fresh attention after recent trading data showed the stock flat over the past day, slightly higher over the past month, and sharply positive over the past 3 months and year. See our latest analysis for Apellis Pharmaceuticals. The latest share price of $40.97 sits alongside a 90 day share price return of 76.98% and a 1 year total shareholder return of 114.28%. The 3 and 5 year total shareholder returns remain...

Wondering if HCI Group at around US$154 per share still offers value, or if most of the opportunity is already priced in. The stock has been choppy recently, with a 2.1% decline over the last 7 days, a 1.1% gain over the last month, and returns of 6.2% over 1 year and very large gains over 3 and 5 years. Recent coverage around the stock has focused on its long run-up over the past few years and how sentiment has shifted as the year to date return stands at a 15.8% decline. Together, these...

TG Therapeutics, Inc. has reported its first-quarter 2026 results, with revenue rising to US$204,920,000 from US$120,860,000 a year earlier and net income increasing to US$19,780,000 from US$5,060,000, lifting basic earnings per share from continuing operations to US$0.14 and diluted earnings per share to US$0.12. The strong quarterly performance underscores ongoing traction for Briumvi in multiple sclerosis and sets the backdrop for the company’s planned subcutaneous formulation launch,...

Q1 2026 results: earnings reset after a strong year CNA Financial (CNA) opened 2026 with Q1 revenue of US$3.7b and basic EPS of US$0.78 on net income of US$211m, setting a different tone from the higher quarterly earnings seen through 2025. Over the past year, revenue has ranged from US$3.6b to US$3.8b per quarter while basic EPS moved between US$0.08 and US$1.49, feeding into trailing 12 month EPS of US$4.48 and net income of US$1.2b as margins have shifted quarter to quarter. For investors,...

Q1 2026 results reset the earnings baseline Loews (L) opened 2026 with Q1 revenue of US$4.6b and basic EPS of US$1.63, alongside net income of US$337m and a reported combined ratio of 102.2%. Over the past year, the company has seen revenue move from US$4.5b in Q1 2025 to US$4.6b in Q1 2026, while trailing twelve month EPS sits at US$7.88 on net income of US$1.63b. With trailing net profit margin at 8.8% and the latest quarter showing a combined ratio above 100%, the update gives investors a...

Donaldson Company (NYSE:DCI) has completed its acquisition of Facet Filtration. The deal expands Donaldson's reach into aerospace, defense, and power generation end markets. The acquisition broadens the Industrial Solutions segment and diversifies the company's revenue base. Donaldson Company, trading at $86.28, has seen its stock return 32.7% over the past year and 41.9% over three years, with a 47.3% return over five years. The completion of the Facet Filtration acquisition adds new...

Kadant Inc. has already reported first-quarter 2026 results, posting sales of US$281.51 million and net income of US$25.51 million, both higher than a year earlier, with basic and diluted EPS from continuing operations rising to US$2.16. This combination of revenue and earnings growth, following earlier expectations for a rebound from last year’s decline, highlights improving operating momentum and confidence in Kadant’s underlying demand drivers. We’ll now examine how Kadant’s higher...

Investors may be asking whether MongoDB stock is still priced attractively after its performance in recent years, or if much of the easier upside has already been realized. The share price last closed at US$266.68, with returns of 3.3% over 7 days, 5.4% over 30 days, a year-to-date decline of 33.3%, and 54.8% over 1 year. Recent market attention on MongoDB has focused on its role in database and developer tooling, with investors reacting to product updates and partnerships that keep it in...

In late April 2026, Starbucks reported second‑quarter results showing year‑over‑year growth in revenue and net income, raised its full‑year earnings outlook, and then in early May launched cash tender offers of up to US$1.10 billion to repurchase portions of eight senior note issues. Together, the stronger earnings, improved guidance, and planned debt repurchases highlight how the “Back to Starbucks” turnaround and balance sheet management are reshaping the company’s financial profile. Next,...

Polestar Automotive Holding UK: What Recent Returns Signal for Investors Polestar Automotive Holding UK (PSNY) has attracted attention after a sharp move in its share price over the past 3 months, in contrast with weaker returns over the past year and since listing. Over the past day and week, the stock has posted mixed short term returns, with a slight 1 day decline and a positive move of about 6% over the past week. Over the month, the stock shows a 4% decline, while the past 3 months...

Investors watching Diversified Healthcare Trust (DHC) got fresh numbers for Q1 2026, with funds from operations (FFO) of US$22.8 million and FFO per share of US$0.09 setting the tone for the latest update. Over recent quarters the company has seen quarterly FFO move from US$11.8 million in Q4 2024 to US$13.6 million in Q2 2025, then to US$4.9 million in Q4 2025 before reaching US$22.8 million in Q1 2026. Trailing twelve month FFO per share sits at US$0.15 against a backdrop of continuing net...

Why Versigent (VGNT) Is On Investors’ Radar Today Versigent (VGNT) has drawn fresh attention after recent trading, with the stock last closing at $37.50 and showing double digit returns over the past week and month. See our latest analysis for Versigent. The recent 1-day share price return of 3.7% and 30-day share price return of 33.5%, on top of a 24.2% year to date share price return, point to momentum building rather than fading for Versigent. If you are looking for other ideas while...

If you are wondering whether Old Republic International at around US$39.25 still offers value after a strong multi year run, it helps to break the story into recent returns, news flow, and what different valuation tools are actually saying. The stock is currently down 2.3% over the last week and 2.8% over the last month, with a 9.3% decline year to date, yet it still shows a 12.3% return over 1 year and triple digit returns over 3 and 5 years. Recent news coverage around Old Republic...

Navigator Holdings Ltd. has released its first-quarter 2026 results, reporting revenue of US$140.62 million versus US$151.41 million a year earlier, while net income rose to US$35.46 million from US$27.04 million, lifting diluted EPS from continuing operations to US$0.54 from US$0.39. The combination of lower revenue but higher earnings and EPS points to improved profitability and cost discipline, which could influence how investors assess the company’s efficiency and earnings...